Trends in Usage and Clinical Outcomes of Coronary Atherectomy: A Report From the National Cardiovascular Data

Nirat Beohar1,2, Lisa A Kaltenbach3, Daniel Wojdyla3

  • 1NewYork-Presbyterian Hospital/Columbia University Medical Center (N.B., M.B.L., J.W.M., A.J.K.).

Insights

Coronary atherectomy (CA) use increased from 2009-2016, with higher hospital volumes linked to fewer major adverse cardiac events. However, increased CA use also correlated with a small rise in coronary perforation risk.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Health Services Research

Background:

  • Adjunctive coronary atherectomy (CA) is used for severe calcified coronary lesions.
  • Temporal trends, patient selection, and use variation of CA remain underdescribed.
  • Understanding CA utilization patterns is crucial for optimizing percutaneous coronary intervention (PCI).

Purpose of the Study:

  • To assess temporal trends in coronary atherectomy (CA) utilization.
  • To evaluate interhospital variability in CA use.
  • To determine the outcomes associated with CA in patients undergoing percutaneous coronary intervention (PCI).

Main Methods:

  • Analysis of 3,864,377 patients undergoing PCI in the CathPCI Registry (July 2009–December 2016).
  • Stratification of CA utilization by time intervals and hospital annual CA volumes.
  • Primary outcome: in-hospital major adverse cardiac events (MACE) including mortality, myocardial infarction, or stroke.

Main Results:

  • Coronary atherectomy (CA) constituted 1.7% of PCI procedures, with utilization increasing from 1.1% to 3.0% between 2009 and 2016.
  • Higher hospital CA volumes were associated with reduced mortality and PCI failure/complication rates requiring coronary artery bypass grafting.
  • An increase in CA utilization correlated with a temporal decline in MACE and myocardial infarction, but also a slight increase in coronary perforation.

Conclusions:

  • Coronary atherectomy (CA) use is increasing despite infrequent application.
  • Higher institutional CA volume is linked to improved patient outcomes, including lower mortality and fewer complications.
  • The benefits of increased CA volume must be weighed against a small but significant risk of coronary perforation.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
191
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
159
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
195
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
280
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
543
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
633